DSGN
Design Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:21:10 PM EST
9.29USD-1.901%(-0.18)160,651
DSGN Financials
In Q3 FY 2026 (ended ), Design Therapeutics, Inc. Common Stock (DSGN) reported revenue of $0, net income of −$20.29M, operating cash flow of −$15.38M, and assets of $216.81M (filed ).
Loading financial flows…